Yuichiro Ozeki

Yuichiro Ozeki

Auto-generated profile, based on publicly available information

Yuichiro Ozeki

Division of Endoscopy, Yokohama City University Medical Center, Yokohama, Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2020 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MNMasafumi Nishio
Masafumi Nishio
KHKingo Hirasawa
Kingo Hirasawa
YOYuichiro Ozeki
Yuichiro Ozeki
ASAtsushi Sawada
Atsushi Sawada
RIRyosuke Ikeda
Ryosuke Ikeda
Shin MaedaShin Maeda
Shin Maeda

13 September 2022 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
YOYuichiro Ozeki
Yuichiro Ozeki
KHKingo Hirasawa
Kingo Hirasawa
ASAtsushi Sawada
Atsushi Sawada
RIRyosuke Ikeda
Ryosuke Ikeda
MNMasafumi Nishio
Masafumi Nishio
Shin MaedaShin Maeda
Shin Maeda

1 January 2020 in Annals of Gastroenterology
Verified
Journal Article
Open access
MNMasafumi Nishio
Masafumi Nishio
KHKingo Hirasawa
Kingo Hirasawa
YOYuichiro Ozeki
Yuichiro Ozeki
ASAtsushi Sawada
Atsushi Sawada
RIRyosuke Ikeda
Ryosuke Ikeda
SMShin Maeda
Shin Maeda
Endoscopic resection is recommended for non-ampullary duodenal neuroendocrine tumors (NAD-NETs) ≤10 mm in diameter and confined to the submucosal layer, without lymph node or distant metastasis. However, the efficacy and safety of endoscopic submucosal dissection (ESD) for NAD-NET remains unclear. The aim of this study was to assess the short-term efficacy and safety and the long-term outcomes of ESD for NAD-NET. Eight patients with 8 NAD-NETs who underwent ESD between 2015 and 2018 were included. The indications for ESD were: i) tumor ≤10 mm in diameter; ii) NET G1; iii) confined to the submucosal layer; and iv) without lymph node or distant metastasis. We retrospectively assessed the short- and long-term outcomes and safety. The median patient age was 69 (48-76) years. All tumors were located in the duodenal bulb and showed 0-Is morphology. The median size was 6.4 (3-9.3) mm. The rates of en bloc resection, histologically free horizontal and vertical margins, and curative resection were 100%, 88%, and 88%, respectively. Intraoperative and postoperative perforation each occurred in 13% of patients, all of whom were treated conservatively and avoided emergent surgery. Delayed bleeding was not observed. No local, lymph node or distant recurrence was observed during a median follow-up period of 34 (18.5-62.5) months. The rates of en bloc and curative resection, and histologically free margins were sufficiently high. Although intraoperative and postoperative perforations occurred, emergency surgery was not needed. The results show that ESD is an efficacious and safe treatment for NAD-NET.

6 October 2022 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
MNMasafumi Nishio
Masafumi Nishio
KHKingo Hirasawa
Kingo Hirasawa
SCSawako Chiba
Sawako Chiba
YOYuichiro Ozeki
Yuichiro Ozeki
ASAtsushi Sawada
Atsushi Sawada
Shin MaedaShin Maeda
Shin Maeda
Endoscopic resection (ER) is feasible for treating well-circumscribed dysplasia in patients with ulcerative colitis (UC). However, long-term prognosis of ER for high-grade dysplasia (HGD) in patien...


18 June 2022 in DEN Open
Verified
Journal Article
Open access
RIRyosuke Ikeda
Ryosuke Ikeda
KHKingo Hirasawa
Kingo Hirasawa
YOYuichiro Ozeki
Yuichiro Ozeki
ASAtsushi Sawada
Atsushi Sawada
MNMasafumi Nishio
Masafumi Nishio
Shin MaedaShin Maeda
Shin Maeda
A 45‐year‐old man underwent esophagogastroduodenoscopy because of symptoms of laryngopharyngeal discomfort. We found a protruded reddish lesion adjacent to the ectopic gastric mucosa (EGM) in the cervical esophagus, and a biopsy revealed that it was a tubular adenocarcinoma. We diagnosed the patient with intramucosal cancer and performed endoscopic submucosal dissection. Esophageal endoscopic submucosal dissection was performed under general anesthesia using a conventional procedure. The resected tumor measured 23 × 14 mm and was adjacent to the EGM. Histologically, the tumor cells showed moderately well‐differentiated adenocarcinoma confined to the muscularis mucosa with no lymphovascular infiltration. Immunohistochemically, the tumor cells were positive for intestinal markers, namely MUC2 and CD10, and negative for gastric markers, namely MUC5AC and MUC6. The patient had no post‐endoscopy submucosal dissection stenosis and remained disease‐free without local recurrence. EGM of the cervical esophagus develops from the columnar epithelium during embryonic development. There are few reports on endoscopic submucosal dissection for mucosal cancer. Of these, immunostaining was performed in three cases. All were positive for MUC5AC and MUC6 and negative for MUC2 and CD10. Usually, EGM shows gastric type epithelium, but occasional cases with intestinal metaplasia, which show positivity for MUC2 and CD10, have been reported. Therefore, we consider this to be an extremely rare case of esophageal adenocarcinoma arising from intestinal metaplasia within the EGM.